Lilly and Hims partner to offer weight-loss medicines through telehealth platform
Eli Lilly & Co. and Hims & Hers Health Inc. announced a partnership to give Hims customers direct access to Lilly’s weight-loss medicines at discounted prices through the telehealth platform. The agreement includes access to Lilly’s new obesity pill Foundayo, which costs $149 a month at the lowest dose, while Zepbound starts at $299 a month.